TriangleNCT02743442 · STUDY IN CONTEXT
Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland
Draft scope assessment: narrower. Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm. Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
Read the full study record and all posted results →
Linked outcomes
Number of patients in which the entire sella turcica (including its anterior face) is seen during surgery and reached by the robotic arms
Total duration of surgery: installation, mucosal time, sphenoidal time, resection and closure
An adverse event occurring after the procedure is serious if it causes death, endangers the life of the person who is suitable for research, requires or prolongs hospitalization, causes a significant handicap, results in a congenital malformation, or is considered medically significant.
Duration of hospitalization after surgery
Reported safety
Quality of life and patient-reported measures
No linked quality-of-life measure is recorded for this setting and study.
Full draft applicability and source-link record
- trial
- release id
- clinical-indications-draft-1
- disease state id
- ds-pituitary-tumors
- nct id
- NCT02743442
- trial label
- Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland
- applicability
- narrower
- applicability note
- Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm.
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- provenance class
- registry-condition-search
- discovery note
- Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
- outcome Count
- 4
- harms Count
- 1
- qol Count
- 0
- outcomes
- release id
- clinical-indications-draft-1
- disease state id
- ds-pituitary-tumors
- nct id
- NCT02743442
- outcome key
- om-0000
- source section id
- NCT02743442-om-0000
- source outcome index
- 0
- endpoint
- Number of Patients Operated Via da Vinci Robot
- endpoint definition
- Number of patients in which the entire sella turcica (including its anterior face) is seen during surgery and reached by the robotic arms
- time origin
- 1 day
- analysis role
- primary
- reporting status
- POSTED
- data cutoff
- Source null
- population note
- Among the 8 patients enrolled in this study, 7 were operated using the Vinci robot. The surgery was canceled for one patient with acute coronary syndrome (a serious adverse event not related to the study).
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-pituitary-tumors
- nct id
- NCT02743442
- outcome key
- om-0001
- source section id
- NCT02743442-om-0001
- source outcome index
- 1
- endpoint
- Duration of Surgery
- endpoint definition
- Total duration of surgery: installation, mucosal time, sphenoidal time, resection and closure
- time origin
- 3 hours
- analysis role
- secondary
- reporting status
- NOT_POSTED
- data cutoff
- Source null
- population note
- Source null
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-pituitary-tumors
- nct id
- NCT02743442
- outcome key
- om-0002
- source section id
- NCT02743442-om-0002
- source outcome index
- 2
- endpoint
- Number of Severe Adverse Events
- endpoint definition
- An adverse event occurring after the procedure is serious if it causes death, endangers the life of the person who is suitable for research, requires or prolongs hospitalization, causes a significant handicap, results in a congenital malformation, or is considered medically significant.
- time origin
- 6 months
- analysis role
- secondary
- reporting status
- NOT_POSTED
- data cutoff
- Source null
- population note
- Source null
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-pituitary-tumors
- nct id
- NCT02743442
- outcome key
- om-0003
- source section id
- NCT02743442-om-0003
- source outcome index
- 3
- endpoint
- Duration of Hospitalization
- endpoint definition
- Duration of hospitalization after surgery
- time origin
- 1 month
- analysis role
- secondary
- reporting status
- NOT_POSTED
- data cutoff
- Source null
- population note
- Source null
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- arms
- release id
- clinical-indications-draft-1
- disease state id
- ds-pituitary-tumors
- nct id
- NCT02743442
- outcome key
- om-0000
- arm key
- OG000
- arm label
- Transoral Surgery
- regimen
- Surgery of the pituitary adenoma via a transoral approach assisted by the da Vinci® Si™ robot
- analyzed count
- 7
- analyzed unit
- Participants
- is comparator
- Source null
- source pointer
- NCT02743442-om-0000#groups/OG000
- harms
- release id
- clinical-indications-draft-1
- disease state id
- ds-pituitary-tumors
- nct id
- NCT02743442
- harm key
- EG000
- source section id
- NCT02743442-ae
- event group key
- EG000
- event group label
- Transoral Surgery
- serious affected
- 4
- serious at risk
- 8
- other affected
- 7
- other at risk
- 8
- frequency threshold
- 0
- collection period
- 6 months
- event definition
- Definition of an adverse event: any harmful manifestation occurring in a person who is amenable to research involving the human person, whether or not the event is related to the research or product to which the research relates. Definition of a serious adverse event: any adverse event that causes death, is life-threatening, requires hospitalization or prolongation, causes disability, results in a congenital malformation, and any event considered medically significant.
- undenominated note
- Source null
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- quality of life
- setting source links
Preserved source evidence · Not medical advice